R.S.V. infections and infant deaths

Urquhart, G E; Gibson, A A
July 1970
British Medical Journal;7/11/1970, Vol. 3 Issue 5714, p110
Academic Journal
No abstract available.


Related Articles

  • Impact of respiratory syncytial virus in the United States. Robinson, Renee F. // American Journal of Health-System Pharmacy;12/1/2008, Vol. 65 Issue 23, pS3 

    Purpose. Respiratory syncytial virus (RSV) infection is most common in infants and young children, with almost all children experiencing at least one infection by their second birthday. Summary. RSV is the leading cause of upper and lower respiratory tract infections in infants and young...

  • Respiratory syncytial virus market. Storey, Shane // Nature Reviews Drug Discovery;Jan2010, Vol. 9 Issue 1, p15 

    The article offers information about the respiratory syncytial virus (RSV) infections and the market of their treatment. These infections are considered as the primary cause of viral death in infants. It notes that the development of RSV vaccines has specific challenges with distant prospect on...

  • Maternal Effects of Respiratory Syncytial Virus Infection during Pregnancy. Wheeler, Sarahn M.; Dotters-Katz, Sarah; Heine, R. Phillip; Grotegut, Chad A.; Swamy, Geeta K. // Emerging Infectious Diseases;Nov2015, Vol. 21 Issue 11, p1951 

    Given the illness and deaths caused by respiratory syncytial virus (RSV) infection during the first year of life, preventing infant RSV infections through maternal vaccination is intriguing. However, little is known about the extent and maternal effects of RSV infection during pregnancy. We...

  • Respiratory syncytial virus infection and invasive meningococcal disease: is there an association? Kneyber, Martin C. J.; van Vught, Adrianus J. // European Journal of Pediatrics;2003, Vol. 162 Issue 5, p352 

    Reports on the association between respiratory syncytial virus (RSV) and invasive meningococcal disease. Information on RSV and invasive meningococcal disease; Infections seen in the patients with meningococcal disease; Detection of RSV in infants.

  • Preventing RSV Infection in At-risk Infants: Current and Emerging Strategies. Todd, Frances E.; Roberg, Kathleen A.; Welliver, Robert C. // Pediatric Nursing;Nov2010 Supplement, p3 

    The article discusses strategies for preventing respiratory syncytial virus (RSV) infection in at-risk infants, such as those whose immune systems have been compromised. An overview of RSV infections, including the manifestations of RSV infections, such as bronchiolitis, incidence of RSV...

  • Viruslike Particle Vaccine Induces Protection Against Respiratory Syncytial Virus Infection in Mice. Fu-Shi Quan; Yonghwan Kim; Sujin Lee; Hong Yi; Sang-Moo Kang; Bozja, Jadranka; Moore, Martin L.; Compans, Richard W. // Journal of Infectious Diseases;10/1/2011, Vol. 204 Issue 7, p987 

    Background. Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis and viral death in infants. Despite decades of research with traditional or subunit vaccine approaches, there are no approved RSV vaccines. New approaches are therefore urgently needed to develop effective RSV...

  • Interferon gamma Profile in Egyptian Infants with Respiratory Syncytial Virus bronchiolitis. Omran, Maha E.; Fahmy, Mohamed AE.; Zaher, Manal M. // Egyptian Journal of Hospital Medicine;Mar2008, Vol. 30, p1 

    Viral bronchiolitis is one of the leading causes for hospitalization of infants in the world and causes an estimated one million deaths per year worldwide. Respiratory syncytial virus (RSV) is associated with the majority of cases. During the last few years it has become increasingly clear that...

  • An Active Surveillance and Referral Program to Ensure Respiratory Syncytial Virus Prophylaxis for the Pediatric Congenital Heart Disease Population: A Quality Improvement Project. DeMare, Carman R.; O’Keefe, Catherine // Clinical Scholars Review;2014, Vol. 7 Issue 2, p154 

    Background: Congenital heart disease (CHD) is the leading cause of death within the first year of life because of birth defects. Complications related to respiratory infection caused by respiratory syncytial virus (RSV) increase risks in the CHD population. Prevention is key to minimizing risk,...

  • RIBAVIRIN FOR RSV LOWER RESPIRATORY TRACT INFECTION. Zamorski, Mark // Journal of Family Practice;Dec1996, Vol. 43 Issue 6, p536 

    The article focuses on a study which attempts to determine whether aerosolized ribavirin offers clinically significant benefits to high-risk infants with lower respiratory tract infections, caused by respiratory syncitial virus (RSV). Initial evaluation of the expensive antiviral drug ribavirin...

  • Management and Prevention Strategies for Respiratory Syncytial Virus (RSV) Bronchiolitis in Infants and Young Children: A Review of Evidence-Based Practice Interventions. Cooper, Allison C.; Banasiak, Nancy Cantey; Allen, Patricia Jackson // Pediatric Nursing;Nov/Dec2003, Vol. 29 Issue 6, p452 

    Respiratory syncytial virus (RSV) is the most common cause of bronchiolitis and pneumonia among infants and children. The purpose of this paper is to review the epidemiology, etiology, pathophysiology, clinical manifestations, risk factors, and assessment of RSV infection in infants and young...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics